Candelanza, Christine B.
HRN: 16-36-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
CEFTRIAXONE 1G (VIAL)
06/03/2022
06/10/2022
IV
750mg
Q12
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes